Daniel Gordon Kirby

Other Executive · IOVANCE BIOTHERAPEUTICS, INC.

Rank #26,001 SEC EDGAR (United States) ↗ Files from United States

Details

Officer of the companyPharmaceuticals & BiotechnologyIOVASEC CIK 0002055001

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$1.2M
1-day change
▲ 1.03%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$274.6K – $1.2M2026-09-04

Insider activity Jun 5, 2025 – Feb 24, 2026

Daniel Gordon Kirby is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 5 transactions between Jun 5, 2025 and Feb 24, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$55.2K
1 purchase on file priced rows only
Open-market sales (code S)
None
0 sales on file
All reported transactions
5
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought IOVANCE BIOTHERAPEUTICS, INC. (IOVA) shares worth $107,194 between May 14, 2025 and Jun 5, 2025

Cluster buying

3 different insiders made 3 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

3 insiders bought IOVANCE BIOTHERAPEUTICS, INC. (IOVA) shares worth $107,194 between May 14, 2025 and Jun 5, 2025
Date Insider Transaction Shares Price Value Filing
May 14, 2025 Frederick G Vogt P Open-market purchase 25,000 held after: 374,646 $1.69 $42,250 SEC filing ↗
May 23, 2025 Raj K Puri P Open-market purchase 5,600 held after: 206,852 $1.74 $9,744 SEC filing ↗
Jun 5, 2025 Daniel Gordon Kirby P Open-market purchase 30,000 held after: 30,000 $1.84 $55,200 SEC filing ↗

Total of the rows above: $107,194, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 9 most recent rows are grouped into 9 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. IOVANCE BIOTHERAPEUTICS, INC. IOVA F Shares withheld for taxesnot a buy/sell decision 2,436 shares $15.6K at $6.40 SEC filing ↗
  2. IOVANCE BIOTHERAPEUTICS, INC. IOVA M Option exercise or conversionnot a buy/sell decisionreported at zero 10,001 shares $0 at $0.00 SEC filing ↗
  3. IOVANCE BIOTHERAPEUTICS, INC. IOVA F Shares withheld for taxesnot a buy/sell decision 2,435 shares $9.0K at $3.70 SEC filing ↗
  4. IOVANCE BIOTHERAPEUTICS, INC. IOVA M Option exercise or conversionnot a buy/sell decisionreported at zero 10,000 shares $0 at $0.00 SEC filing ↗
  5. IOVANCE BIOTHERAPEUTICS, INC. IOVA F Shares withheld for taxesnot a buy/sell decision 34,165 shares $129.1K at $3.78 SEC filing ↗
  6. IOVANCE BIOTHERAPEUTICS, INC. IOVA M Option exercise or conversionnot a buy/sell decisionreported at zero 120,000 shares $0 at $0.00 SEC filing ↗
  7. IOVANCE BIOTHERAPEUTICS, INC. IOVA F Shares withheld for taxesnot a buy/sell decision 16,450 shares $42.8K at $2.60 SEC filing ↗
  8. IOVANCE BIOTHERAPEUTICS, INC. IOVA M Option exercise or conversionnot a buy/sell decisionreported at zero 39,996 shares $0 at $0.00 SEC filing ↗
  9. IOVANCE BIOTHERAPEUTICS, INC. IOVA P Open-market purchase 30,000 shares $55.2K at $1.84 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
IOVANCE BIOTHERAPEUTICS, INC. IOVA Common Stock 139,381 $8.79 $1.2M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Daniel Gordon Kirby reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.